Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McMaster University

$39,000.00

Development of New Synthons and Catalysts and Applications in Organic Synthesis

EF 2023-24

Résumé
The research program expands on a large body of research concerning the synthesis of functionalized alkenes developed in my group over the last 20 years. These substrates include stereochemically (E or Z) defined electron rich alkenes, styrenes, stilbenes, unsaturated aldehydes and ketones, vinyl ethers and alkoxy dienes. These substrates have served as key building blocks for the development of catalytic transformations allowing access to the core structures found in complex bioactive natural products, such as alkaloids, polyketides, lignans and terpenoids. A second aspect of the program concerns the development of new catalysts based mainly on late transition metal complexes and organic catalysts such as chiral amines, chiral phosphoric acids (CPAs) or H-bonding catalysts and development of cascade reaction sequences. Two main methods of activation will be investigated. The first type is generally based on pi-activation of functionalized alkenes employing late transition metal and CPA, catalysts. We propose the development of new halogen bonding catalysts for alkene activation/cyclization that do not introduce nucleophilic halogens to the substrate, as a mimic of typeII biological cyclization processes active in natural product biosynthesis. The second type of activation mode is to use chiral secondary amines and also newly proposed primary amines to initiate enamine or iminium ion initiated catalytic processes. The third aspect of the program concerns the applications of the methodology developed towards the asymmetric synthesis of biologically important natural products and small molecules. A major focus of the present methodology is to access key substrates leading to compounds with potent antiviral and anticancer activity. The need to access complex core structures of new experimental antiviral agents could not be more pertinent given the recent coronavirus pandemic (SARSCoV2, RNA virus) and monkeypox (double strand DNA virus) outbreak. The proposal will describe the preparation of functionalized alkene substrates setup to convert to the core structures of alkaloids known to have potent antiviral activity to DNA and RNA viruses and which can also be converted to alternate substrates with nanomolar anticancer activity. The applications of our methodology to convert planar designed functionalized alkenes into complex chiral skeletons and to key natural product targets has proven very powerful and allowed to synthesis of many natural products and analogs over the last decade. We propose to continue this and further develop this methodology to access new structural types.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2023-04827
Name nom
McNulty, James
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
39000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Development of New Synthons and Catalysts and Applications in Organic Synthesis
Keyword
Alkaloids; Anticancer agents; Antiviral agents; Asymmetric synthesis; Cascade Reactions; Functionalized olefins; Natural products; Organocatalysis; Synthetic methodology
Application summary
The research program expands on a large body of research concerning the synthesis of functionalized alkenes developed in my group over the last 20 years. These substrates include stereochemically (E or Z) defined electron rich alkenes, styrenes, stilbenes, unsaturated aldehydes and ketones, vinyl ethers and alkoxy dienes. These substrates have served as key building blocks for the development of catalytic transformations allowing access to the core structures found in complex bioactive natural products, such as alkaloids, polyketides, lignans and terpenoids. A second aspect of the program concerns the development of new catalysts based mainly on late transition metal complexes and organic catalysts such as chiral amines, chiral phosphoric acids (CPAs) or H-bonding catalysts and development of cascade reaction sequences. Two main methods of activation will be investigated. The first type is generally based on pi-activation of functionalized alkenes employing late transition metal and CPA, catalysts. We propose the development of new halogen bonding catalysts for alkene activation/cyclization that do not introduce nucleophilic halogens to the substrate, as a mimic of typeII biological cyclization processes active in natural product biosynthesis. The second type of activation mode is to use chiral secondary amines and also newly proposed primary amines to initiate enamine or iminium ion initiated catalytic processes. The third aspect of the program concerns the applications of the methodology developed towards the asymmetric synthesis of biologically important natural products and small molecules. A major focus of the present methodology is to access key substrates leading to compounds with potent antiviral and anticancer activity. The need to access complex core structures of new experimental antiviral agents could not be more pertinent given the recent coronavirus pandemic (SARSCoV2, RNA virus) and monkeypox (double strand DNA virus) outbreak. The proposal will describe the preparation of functionalized alkene substrates setup to convert to the core structures of alkaloids known to have potent antiviral activity to DNA and RNA viruses and which can also be converted to alternate substrates with nanomolar anticancer activity. The applications of our methodology to convert planar designed functionalized alkenes into complex chiral skeletons and to key natural product targets has proven very powerful and allowed to synthesis of many natural products and analogs over the last decade. We propose to continue this and further develop this methodology to access new structural types.